The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Bod Australia (BOD) receives US Hemp Authority Certification for its exclusive CBD extract and related products sold under the CBII brand in the US
  • The 12 month process included verification around the company’s CBD extract, stringent lab testing and ensuring operations did not utilise synthetic cannabinoids
  • The certification adds to the company’s ongoing regulatory recognition, which includes UK novel food application and generally recognised as safe status in line with the US Food and Drug Administration safety guidelines
  • Bod sees the certification as another opportunity to increase brand recognition amongst key customers and provides it with another intellectual property asset to leverage and drive revenue streams
  • Shares in Bod are up 4.17 per cent, trading at 10 cents at 12:58 pm AEST

Bod Australia (BOD) has been awarded US Hemp Authority Certification for its exclusive CBD extract and related products sold under the CBII brand in the US.

The program is the hemp industry’s initiative to provide the highest standards, best practices and self-regulation to underpin consumer and retailer confidence in hemp and CBD products.

The process was undertaken over a 12-month period and included verification around the company’s CBD extract, stringent lab testing and ensuring operations do not utilise synthetic cannabinoids.

The certification adds to the company’s ongoing regulatory recognition, which includes the company’s UK novel food application and is generally recognised as safe status in line with the US Food and Drug Administration safety guidelines.

Further, Bod said certification provides another third-party endorsement for its products and adds another competitive advantage in the US.

The company sees this as another opportunity to increase brand recognition amongst key customers and provides Bod with another intellectual property asset to leverage and drive revenue streams.

CEO Jo Patterson said to have passed the testing process validates the “superior” quality of the company’s extract, operations and product development initiatives.

“Having been awarded the certification adds to the growing list of regulatory recognition for Bod’s extract which has already been validated in both the UK and the US,” she said.

“Further, we anticipate that the US Hemp Authority’s seal of approval will provide consumers with added confidence in the company’s products.”

Shares in Bod were up 4.17 per cent, trading at 10 cents at 12:58 pm AEST.

BOD by the numbers
More From The Market Online

Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy

The big thematics and headlines that drove the ASX this week, plus, the headlines I think…
The Market Online Video

Market Close: ASX signs off on a sigh with all sectors red-lining

The ASX200 finished 1.3 per cent down with every sector in the red and Industrials and Real Estate brittle and bruised as bot…
The Market Online Video

Market Update: ASX on red alert with all sectors below the surface

The ASX200 is trading down around 1.1% with all eleven sectors in the red. Real-estate has…

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.